Adverse Outcomes in Pregnant Women Hospitalized With Respiratory Syncytial Virus Infection: A Case Series

• Authors: Anne M Hause, Emory University; Lakshmi Panagiotakopoulos, Centers for Disease Control and Prevention, Atlanta; Eric S Weintraub, Centers for Disease Control and Prevention, Atlanta; Lina S Sy, Kaiser Permanente Southern California; Sungching C Glenn, Kaiser Permanente Southern California; Hung-Fu Tseng, Kaiser Permanente Southern California; Michael M McNeil, Centers for Disease Control and Prevention, Atlanta
• Journal Title: CLINICAL INFECTIOUS DISEASES
• Volume: Volume 72, Number 1
• Publisher: OXFORD UNIV PRESS INC | 2021-01-01, Pages 138-140
• Type of Work: Article | Final Publisher PDF
• Publisher DOI: http://doi.org/10.1093/cid/ciaa668
• Subjects: Health Sciences, Public Health
• Keywords: Science & Technology; Life Sciences & Biomedicine; Immunology; Infectious Diseases; Microbiology; respiratory syncytial virus; pregnancy; respiratory infections; maternal infections; maternal vaccines; INFLUENZA; ILLNESS; VACCINE; IMPACT

Abstract

We identified 10 women hospitalized with respiratory syncytial virus infection during pregnancy. Diagnoses included pneumonia/atelectasis (5), respiratory failure (2), and sepsis (2). Six had obstetrical complications during hospitalization, including 1 induced preterm birth. One required intensive care unit admission and mechanical ventilation. Four infants had complications at birth.